Skip to main content
. 2016 Feb 4;8(4):305–311. doi: 10.4168/aair.2016.8.4.305

Table 5. Effectiveness of montelukast compared to placebo in the atopic eczema group.

Changes after taking Montelukast
(Mean±SD)
Changes after taking Placebo drug
(Mean±SD)
P value
SCORAD index -5.4±8.6 -7.7±10.2 0.51
Urine LTE4 (pg/mL) 4.8±528.0 61.8±661.8 0.72
Urine EDN (ng/mL) 160.5±1,068.6 -6.9±963.3 0.20

SCORAD, SCORing Atopic Dermatitis; LTE4, leukotriene E4; EDN, eosinophil-derived neurotoxin.